Pharmacological pain management in cancer patients

被引：0

作者：

Muetherig, Anke ^{[1
,2
]}

Scheffler, Gesine ^{[3
]}

Schuler, Ulrich S. S. ^{[1
,2
]}

机构：

[1] Univ Klinikum Carl Gustav Carus Dresden, Palliativ Zentrum, Fetscherstr 74, D-01307 Dresden, Germany

[2] Univ Klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, D-01307 Dresden, Germany

[3] Univ Klinikum Carl Gustav Carus Dresden, Klin Apotheke, Dresden, Germany

来源：

ONKOLOGIE | 2023年 / 29卷 / 08期

关键词：

Cancer pain; Analgesics; opioid; Morphine; Acetaminophen; Cannabinoids; ANALGESIC LADDER; MORPHINE; VALIDATION; METHADONE; EFFICACY; OPIOIDS; TRIAL;

D O I：

10.1007/s00761-023-01394-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pharmacological pain therapy in cancer patients is based on guideline recommendations, which, however, do not fully coincide in all aspects due to varying weighting of evidence. The present article discusses current issues including the decreasing significance of the World Health Organization (WHO) analgesic ladder, with its distinction between step 2 and 3 being increasingly questioned. Risks of nonopioid analgesics such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), particularly in older populations, are discussed. Paracetamol may potentially reduce the effectiveness of immunotherapies. Aspects of administering analgesics via a feeding tube are considered. Recommendations for the treatment of episodic pain, transitioning between different opioids, and some relevant interactions are also discussed.

引用

页码：727 / 736

页数：10

共 50 条

[31] Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC")
Davies, Andrew
Fagan, Norah
Gonzalez-Barboteo, Jesus
Chelazzi, Cosimo
Economos, Guillaume
Elsner, Frank
Leach, Charlotte
Monsen, Ragnhild E.
Oldenmenger, Wendy H.
Remi, Constanze
van den Beuken-van Everdingen, Marieke
Wuestefeld, Marion
SUPPORTIVE CARE IN CANCER, 2024, 32 (10)
[32] Methadone as First-line Opioid for the Management of Cancer Pain
Mercadante, Sebastiano
Adile, Claudio
Ferrera, Patrizia
Pallotti, Maria Caterina
Ricci, Marianna
Bonanno, Giuseppe
Casuccio, Alessandra
ONCOLOGIST, 2022, 27 (04) : 323 - 327
[33] Interindividual Variation of Pharmacokinetic Disposition of and Clinical Responses to Opioid Analgesics in Cancer Pain Patients
Naito, Takafumi
Kawakami, Junichi
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (05): : 709 - 715
[34] Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain
De Rosa, Federica
Giannatiempo, Bruno
Charlier, Bruno
Coglianese, Albino
Mensitieri, Francesca
Gaudino, Giulia
Cozzolino, Armando
Filippelli, Amelia
Piazza, Ornella
Dal Piaz, Fabrizio
Izzo, Viviana
PHARMACEUTICS, 2023, 15 (08)
[35] Levorphanol for Treatment of Intractable Neuropathic Pain in Cancer Patients
Reddy, Akhila
Ng, Amy
Mallipeddi, Tarun
Bruera, Eduardo
JOURNAL OF PALLIATIVE MEDICINE, 2018, 21 (03) : 399 - 402
[36] Low Doses of Transdermal Buprenorphine in Opioid-Naive Patients With Cancer Pain: A 4-Week, Nonrandomized, Open-Label, Uncontrolled Observational Study
Mercadante, Sebastiano
Porzio, Gianpiero
Ferrera, Patrizia
Aielli, Federica
Verna, Lucilla
Tirelli, Walter
Villari, Patrizia
Casuccio, Alessandra
CLINICAL THERAPEUTICS, 2009, 31 (10) : 2134 - 2138
[37] New drugs for pain management in advanced cancer patients
Mercadante, Sebastiano
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (05) : 497 - 502
[38] Breakthrough Pain in Cancer Patients
Zeppetella, G.
CLINICAL ONCOLOGY, 2011, 23 (06) : 393 - 398
[39] The use of opioids for treatment of cancer pain
Mercadante, Sebastiano
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (03) : 389 - 394
[40] The pharmacological management of dental pain
Pergolizzi, Joseph, V
Magnusson, Peter
LeQuang, Jo Ann
Gharibo, Christopher
Varrassi, Giustino
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (05) : 591 - 601

← 1 2 3 4 5 →